Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

AngelosProject Apr. 20 at 10:38 PM

$LION $WMB $LITS $NKLR perf

0 · Reply

SerpentHalo Apr. 17 at 10:50 PM

$LITS

0 · Reply

Trendytraders Apr. 7 at 10:50 PM

$LITS $LTC.X don’t sleep

0 · Reply

End00Game Mar. 31 at 10:32 PM

$FOX.X $LTC.X $LITS $ZEC.X So looking at top holders of Lite Strategy it is Citadel and Renaissance . Litecoin is nose diving not sure what is happening here....

1 · Reply

soccerplayer06 Mar. 31 at 4:35 PM

$LITS looks like the company is using that buyback money today. $LTC.X

3 · Reply

Bestbee Mar. 30 at 5:41 PM

$LITS

0 · Reply

Bohrenn Mar. 27 at 2:04 PM

$LITS Wo starke Verlust zu machen sind, darf der Sharedeals.de No Brainer Club nicht fehlen. Daher natürlich auch bei $LITS bereits zu Kursen um 1,40 USD am 02.01.2026 die Empfehlung zum Kauf. Denn gezielte Verarmung ist am nachhaltigsten wenn sie breit diversifiziert erreicht wird. Die besondere Qualität besteht darin auch außerhalb des Kernbereichs verlässliche Verlierer zu identifizieren.

3 · Reply

Prometheus2 Mar. 26 at 11:27 AM

$LITS subtracting today.. Bitcoin’s isomer has no real value. Insane.

0 · Reply

ggabel7 Mar. 24 at 5:42 PM

well well😍 what’s going on here $CRWV $MSFT $LITS $TSEM I can’t believe retails not all over $EVTV great news plenty of juice to be made when volume comes

0 · Reply

soccerplayer06 Mar. 24 at 9:53 AM

$LITS adding more here today. $LTC.X

1 · Reply

Lite Strategy Reports Fiscal 2026 Second Quarter Results

Sep 10, 2025, 9:00 AM EDT - 7 months ago

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 5, 2025, 8:00 AM EDT - 9 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 9 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 9 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 1:22 PM EDT - 9 months ago

Why Is MEI Pharma Stock Soaring On Friday?

Jul 18, 2025, 8:30 AM EDT - 9 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

May 14, 2024, 10:38 AM EDT - 2 years ago

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

May 9, 2024, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Apr 11, 2024, 8:02 AM EDT - 2 years ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 2 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 3 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 13, 2023, 4:05 PM EDT - 3 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 3 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 3 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 3 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 1, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

May 30, 2023, 5:40 PM EDT - 3 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

AngelosProject Apr. 20 at 10:38 PM

$LION $WMB $LITS $NKLR perf

0 · Reply

SerpentHalo Apr. 17 at 10:50 PM

$LITS

0 · Reply

Trendytraders Apr. 7 at 10:50 PM

$LITS $LTC.X don’t sleep

0 · Reply

End00Game Mar. 31 at 10:32 PM

$FOX.X $LTC.X $LITS $ZEC.X So looking at top holders of Lite Strategy it is Citadel and Renaissance . Litecoin is nose diving not sure what is happening here....

1 · Reply

soccerplayer06 Mar. 31 at 4:35 PM

$LITS looks like the company is using that buyback money today. $LTC.X

3 · Reply

Bestbee Mar. 30 at 5:41 PM

$LITS

0 · Reply

Bohrenn Mar. 27 at 2:04 PM

3 · Reply

Prometheus2 Mar. 26 at 11:27 AM

$LITS subtracting today.. Bitcoin’s isomer has no real value. Insane.

0 · Reply

ggabel7 Mar. 24 at 5:42 PM

well well😍 what’s going on here $CRWV $MSFT $LITS $TSEM I can’t believe retails not all over $EVTV great news plenty of juice to be made when volume comes

0 · Reply

soccerplayer06 Mar. 24 at 9:53 AM

$LITS adding more here today. $LTC.X

1 · Reply

soccerplayer06 Mar. 20 at 2:08 PM

$LITS added some more here. huge potential, especially if they announce more litecoin purchases or mining news. $LTC.X

0 · Reply

soccerplayer06 Mar. 18 at 12:00 PM

$LTC.X no volume right now. Could easily go right back up. $LITS

0 · Reply

hitmongreen Mar. 16 at 5:01 PM

$LITS 🤔

0 · Reply

Ron_Burn Mar. 16 at 12:48 AM

$LITS 👀

0 · Reply

soccerplayer06 Mar. 13 at 12:58 PM

$LITS time to get movin north! 😎💪$LTC.X

0 · Reply

soccerplayer06 Mar. 2 at 1:03 PM

$LITS adding more here. $LTC.X just keep averaging down on these dips.

0 · Reply

End00Game Feb. 27 at 1:44 AM

$LITS patiently awaiting Reverse Split $BMNR

0 · Reply

soccerplayer06 Feb. 26 at 1:15 PM

$LTC.X A lot of volume the last 24 hours. Definitely manipulation in crypto last 6 months. Time for those short sellers to now make money on the way up. $LITS

2 · Reply

soccerplayer06 Feb. 25 at 11:40 PM

$LITS hoping management is buying shares down here…

0 · Reply

soccerplayer06 Feb. 25 at 4:08 PM

$LITS here we go! $LTC.X

0 · Reply

End00Game Feb. 25 at 1:23 AM

$LITS $LTC.X $BMNR $ETH.X no alt season but tons of hype.

0 · Reply

CashCow11 Feb. 23 at 9:57 PM

$LITS $LTC.X over $50 million in losses in 6 months

0 · Reply

Market Cap	42.91M
Revenue (ttm)	0.00
Net Income (ttm)	-15.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	256,500
Avg Vol	291,040
Day's Range	N/A - N/A
Shares Out	36.36M
Stochastic %K	75%
Beta	0.28
Analysts	Hold
Price Target	N/A